Funding for this research was provided by:
Zhejiang medical and health science and technology project (2018261355)
Zhejiang province health high-level talents and Zhejiang province sepsis innovation subject (N/A.)
Received: 11 October 2019
Accepted: 8 January 2020
First Online: 14 January 2020
Ethics approval and consent to participate
: This was a secondary analysis of a prospective RCT [CitationRef removed] that was performed in 10 centers within the ARDS Network of the National Heart, Lung, and Blood Institute research network. The original study was approved by the institutional review board at each study center, and informed consent was obtained from the patients or their legal guardians. All data were uploaded in the Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) (ExternalRef removed) by the ARDS Network. The re-use of these data was approved both by the institutional review board at each center and by BioLINCC. Thus, the need for consent was waived for this retrospective study.
: Not applicable.
: The authors declare that they have no competing interests.